Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Myo Maung Maung Swe and Htet Htet Aung from our MOCRU unit in Myanmar were awarded grants by the International Society for Infectious Diseases and Wellcome. Myo Maung will study antibiotics use and antimicrobial resistance public awareness in Myanmar; Htet Htet will conduct a study on Ethical challenges when offering pregnant women with Hepatitis B short course treatment to prevent transmission.

Dr Myo Maung Maung Swe and Htet Htet Aung

Dr Myo Maung Maung Swe (left), Clinical Researcher and DPhil student at MOCRU, was awarded in August an International Society for Infectious Diseases (ISID) research grant, a signature ISID program that funds infectious disease researchers from LMIC countries with the greatest burden of infectious disease. Myo Maung, a clinical researcher at MOCRU for 3 years, was awarded the ISID research grant to conduct the study Antibiotics use and antimicrobial resistance (AMR) public awareness survey in Myanmar. Myo plans to conduct the study, which aims to understand self-reported antibiotic use, public knowledge of antibiotics and the awareness of antibiotic resistance, in two regions of Myanmar, as yet to be determined. The team will collect data Dec 2018-Jan 2019 and hopes to publish results by April 2019.

That same month, MOCRU Clinical Research Assistant Htet Htet Aung (right) was awarded an Ethox Global Health Bioethics Network (GBHN) Bursary Award. GBHN is funded by a Wellcome Trust Strategic Award aiming to conduct ethics research and improve capacity building across the Wellcome Trust Major Overseas Programmes. Htet Htet, who has worked as a clinical research assistant in MOCRU for a year, will use the GBHN Bursary to conduct the study Ethical challenges related to offering pregnant women with chronic Hep B short course treatment with Tenofovir disoproxil fumarate to prevent vertical transmission in Myanmar. Htet Htet hopes to start the study mid-Oct, once she gets OxTREC and local Ethics Committee approval, and publish results in early June 2019. The study will be conducted at Central Women’s Hospital, Yangon.

Similar stories

Tropical Medicine DPhil Students awarded NDM Prize

Every year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (OCGHR) as second year DPhil student. Our warmest congratulations to you all!

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

There are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.

Congratulations new Associate Professors

Following the meeting of the Medical Sciences Divisional Committee to consider applications for the conferral of the title of Associate Professor, we are pleased to announce that Rashan Haniffa, Dorcas Kamuya, Isabella Oyier, Le Van Tan and Timothy Walker have been awarded the title Associate Professor

COPCOV now world’s largest COVID-19 pre-exposure prophylaxis trial

A 6-week recruitment burst at Aga Khan University in Pakistan led the way as COPCOV enrolment broke 1600 participants. Led by MORU, COPCOV is the world’s largest trial trying to determine if hydroxychloroquine and chloroquine prevent COVID-19.

How did people in Europe and SE Asia experience the first COVID-19 wave?

An international team, led by Phaik Yeong Cheah, conducted an anonymous online survey from May-June 2020, asking 5,058 people in Thailand, Malaysia, United Kingdom, Italy and Slovenia to share their experiences. Anne Osterrieder and colleagues report the unequal impacts of public health measures, and the prevalence of ‘fake news’.

Recruitment surges in COPCOV COVID-19 prevention study

As high COVID-19 daily cases and highly transmissible variants risk overwhelming countries’ healthcare systems, COPCOV, the world’s last-standing large prophylaxis RCT, faces tight timelines to determine whether chloroquine/ hydroxychloroquine prevents COVID-19